Senior Program Manager (SPM), Immunology Medical Evidence Generation (MEG)/Life Cycle Managemen[...]

Main Responsibilities Support building and execution of Global Medical Affairs strategy/plan for Dupilumab related to Integrated Evidence Generation Planning (IEGP). Partner with LCM Leads to ensure synergy between IEGP development and financial planning. Apply a “Glocal” approach for country inclusion/exchange to identify and prioritize data gaps via two-way interaction between local entities and global stakeholders. Implement and execute Medical Evidence Generation operational plans across the dupilumab franchise: data gap generation/prioritization, Medical Brand Planning, IEGP implementation/maintenance, and financial documentation insights; align medical and financial planning for long-range forecasting. Coordinate evidence generation insights with affiliate Medical Directors (G10 and beyond) through regular meetings. Collaborate with alliance partner Regeneron to define consistent evidence strategy with Research/Clinical Development stakeholders. Drive alignment and communication across cross-functional partners (HEVA, Market Access, Translational) and provide reporting to senior leadership and alliance meetings. Maintain medical program management tracking tools; ensure compliance with SOPs/guidelines and optimize workflows through harmonized tools. Build and maintain internal/external partnerships. Qualifications (Base) BS required; advanced science degree preferred; MBA plus. 3+ years project/program management in biotech/pharma or clinical/scientific environment. Lead projects end-to-end; strong PM methodology knowledge; collaborate in matrix environments; create KPI dashboards; strong MS Office and PM software skills. Preferred Biotech/pharma + Project/Program Management; Medical Affairs preferred. Alliance environment experience (e.g., Regeneron coordination). Strong scientific/data communication and understanding of drug development/commercialization. Benefits rewards package; healthcare/wellbeing programs; at least 14 weeks' gender-neutral parental leave. #J-18808-Ljbffr Scorpion Therapeutics